{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:36:08Z","timestamp":1775820968875,"version":"3.50.1"},"reference-count":97,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice & Research Clinical Rheumatology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.berh.2019.101440","type":"journal-article","created":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T17:11:49Z","timestamp":1569949909000},"page":"101440","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Suspected inflammatory rheumatic diseases in patients presenting with skin rashes"],"prefix":"10.1016","volume":"33","author":[{"given":"Francisca","family":"Alves","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margarida","family":"Gon\u00e7alo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.berh.2019.101440_bib1","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1111\/bjd.17636","article-title":"Validation and reliability of a disease-specific quality-of-life measure in patients with cutaneous lupus erythematosus","volume":"180","author":"Ogunsanya","year":"2019","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.berh.2019.101440_bib2","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1111\/bjd.17911","article-title":"Understanding cutaneous lupus erythematosus: a step forward","volume":"180","author":"Albrecht","year":"2019","journal-title":"Br J Dermatol"},{"issue":"10","key":"10.1016\/j.berh.2019.101440_bib3","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.autrev.2016.07.013","article-title":"The skin in autoimmune diseases \u2014 unmet needs","volume":"15","author":"Kuhn","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"4","key":"10.1016\/j.berh.2019.101440_bib4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.clindermatol.2018.04.009","article-title":"Less common rheumatologic disorders: current concepts of skin and systemic manifestations","volume":"36","author":"Paravar","year":"2018","journal-title":"Clin Dermatol"},{"issue":"11","key":"10.1016\/j.berh.2019.101440_bib5","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"Classification criteria for systemic sclerosis: an ACR-EULAR collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.berh.2019.101440_bib6","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/bjd.17536","article-title":"The diagnosis and classification of amyopathic dermatomyositis\u202f: a historical review and assessment of existing criteria","volume":"180","author":"Concha","year":"2019","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.berh.2019.101440_bib7","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.clindermatol.2006.07.014","article-title":"Lupus erythematosus: systemic and cutaneous manifestations","volume":"24","author":"Rothfield","year":"2006","journal-title":"Clin Dermatol"},{"issue":"8","key":"10.1016\/j.berh.2019.101440_bib8","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1177\/0961203319856091","article-title":"Spectrum of cutaneous lupus erythematosus in South Africans with systemic lupus erythematosus","volume":"28","author":"Koch","year":"2019","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2019.101440_bib9","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s00281-015-0550-0","article-title":"Lupus erythematosus revisited","volume":"38","author":"Kuhn","year":"2016","journal-title":"Semin Immunopathol"},{"issue":"4","key":"10.1016\/j.berh.2019.101440_bib10","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0190-9622(81)80261-7","article-title":"Distinctive cutaneous subsets in the spectrum of lupus erythematosus","volume":"4","author":"Gilliam","year":"1981","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.berh.2019.101440_bib11","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.clindermatol.2018.04.002","article-title":"Cutaneous lupus erythematosus: reflecting on practice-changing observations over the past 50 years","volume":"36","author":"Callen","year":"2018","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.berh.2019.101440_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jaut.2014.01.021","article-title":"The classification and diagnosis of cutaneous lupus erythematosus","volume":"49","author":"Kuhn","year":"2014","journal-title":"J Autoimmun"},{"issue":"332","key":"10.1016\/j.berh.2019.101440_bib13","first-page":"1","article-title":"Advancing understanding, diagnosis, and therapies for cutaneous lupus erythematosus within the broader context of systemic lupus erythematosus","volume":"8","author":"Chen","year":"2019","journal-title":"F1000Res"},{"key":"10.1016\/j.berh.2019.101440_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.4103\/2229-5178.126020","article-title":"Cutaneous lupus erythematosus\u202f: an update","volume":"5","author":"Gr\u00f6nhagen","year":"2014","journal-title":"Indian Dermatol Online J"},{"issue":"3","key":"10.1016\/j.berh.2019.101440_bib15","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.autrev.2012.08.019","article-title":"Cutaneous lupus erythematosus: first multicenter database analysis of 1002 patients from the European Society of Cutaneous Lupus Erythematosus (EUSCLE)","volume":"12","author":"Biazar","year":"2013","journal-title":"Autoimmun Rev"},{"issue":"6","key":"10.1016\/j.berh.2019.101440_bib16","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1111\/j.1365-2133.2011.10272.x","article-title":"Cutaneous lupus erythematosus and the association with systemic lupus erythematosus: a population-based cohort of 1088 patients in Sweden","volume":"164","author":"Gronhagen","year":"2011","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.berh.2019.101440_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1546-0096-13-1","article-title":"Mucocutaneous manifestations in juvenile-onset systemic lupus erythematosus\u202f: a review of literature","volume":"13","author":"Chiewchengchol","year":"2015","journal-title":"Pediatr Rheumatol"},{"issue":"6","key":"10.1016\/j.berh.2019.101440_bib18","doi-asserted-by":"crossref","first-page":"365","DOI":"10.2165\/11310780-000000000-00000","article-title":"Cutaneous lupus erythematosus","volume":"10","author":"Walling","year":"2009","journal-title":"Am J Clin Dermatol"},{"issue":"2","key":"10.1016\/j.berh.2019.101440_bib19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.5070\/D38N61708J","article-title":"Nasal septum perforation as the presenting sign of lupus erythematosus","volume":"11","author":"Mascarenhas","year":"2005","journal-title":"Dermatol Online J"},{"issue":"3","key":"10.1016\/j.berh.2019.101440_bib20","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.berh.2013.07.008","article-title":"Cutaneous lupus erythematosus\u202f: diagnosis and treatment","volume":"27","author":"Okon","year":"2013","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.berh.2019.101440_bib21","doi-asserted-by":"crossref","first-page":"664","DOI":"10.7326\/0003-4819-97-5-664","article-title":"Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus","volume":"97","author":"Sontheimer","year":"1982","journal-title":"Ann Intern Med"},{"issue":"1","key":"10.1016\/j.berh.2019.101440_bib24","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000018307","article-title":"Clinical, histological and immunopathological features of 58 patients with subacute cutaneous lupus erythematosus","volume":"200","author":"Parodi","year":"2000","journal-title":"Dermatology"},{"issue":"1","key":"10.1016\/j.berh.2019.101440_bib25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-4362.2001.01067-5.x","article-title":"Subacute cutaneous lupus erythematosus with pityriasis-like cutaneous manifestations","volume":"40","author":"Caproni","year":"2001","journal-title":"Int J Dermatol"},{"issue":"12","key":"10.1016\/j.berh.2019.101440_bib26","first-page":"1124","article-title":"Clinical manifestations of cutaneous lupus erythematosus","volume":"5","author":"Kuhn","year":"2007","journal-title":"J Ger Soc Dermatol JDDG"},{"issue":"1","key":"10.1016\/j.berh.2019.101440_bib27","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1111\/j.1365-2133.2011.10610.x","article-title":"Determining risk factors for developing systemic lupus erythematosus in patients with discoid lupus erythematosus","volume":"166","author":"Chong","year":"2012","journal-title":"Br J Dermatol"},{"issue":"1","key":"10.1016\/j.berh.2019.101440_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1365-2133.2009.09472.x","article-title":"Comparative analysis of subacute cutaneous lupus erythematosus and chronic cutaneous lupus erythematosus: clinical and immunological study of 270 patients","volume":"162","author":"Vera-Recabarren","year":"2010","journal-title":"Br J Dermatol"},{"issue":"2","key":"10.1016\/j.berh.2019.101440_bib29","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2133.2004.06308.x","article-title":"The combination of complement deficiency and cigarette smoking as risk factor for cutaneous lupus erythematosus in men; a focus on combined C2\/C4 deficiency","volume":"152","author":"Boeckler","year":"2005","journal-title":"Br J Dermatol"},{"issue":"7","key":"10.1016\/j.berh.2019.101440_bib30","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2165\/00128071-200304070-00002","article-title":"Cutaneous lupus erythematosus","volume":"4","author":"Fabbri","year":"2003","journal-title":"Am J Clin Dermatol"},{"issue":"1","key":"10.1016\/j.berh.2019.101440_bib31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1053\/sder.2001.23091","article-title":"Cutaneous lupus erythematosus","volume":"20","author":"McCauliffe","year":"2001","journal-title":"Semin Cutan Med Surg"},{"issue":"8","key":"10.1016\/j.berh.2019.101440_bib32","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s10067-008-0942-9","article-title":"Chilblain lupus erythematosus\u2014a review of literature","volume":"27","author":"Hedrich","year":"2008","journal-title":"Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.berh.2019.101440_bib33","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1365-2133.2012.10813.x","article-title":"Inherited or de novo mutation affecting aspartate 18 of TREX1 results in either familial chilblain lupus or Aicardi-Goutieres syndrome","volume":"167","author":"Tungler","year":"2012","journal-title":"Br J Dermatol"},{"issue":"6","key":"10.1016\/j.berh.2019.101440_bib34","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.autrev.2008.12.010","article-title":"The 100th anniversary of lupus erythematosus tumidus","volume":"8","author":"Kuhn","year":"2009","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.berh.2019.101440_bib35","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/archderm.136.8.1033","article-title":"Lupus erythematosus tumidus--a neglected subset of cutaneous Lupus erythematosus: report of 40 cases","volume":"136","author":"Kuhn","year":"2000","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.berh.2019.101440_bib36","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/j.1365-2133.2009.09401.x","article-title":"Lupus erythematosus tumidus is a separate subtype of cutaneous lupus erythematosus","volume":"162","author":"Schmitt","year":"2009","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.berh.2019.101440_bib37","doi-asserted-by":"crossref","DOI":"10.5070\/D3245040100","article-title":"Toxic epidermal necrolysis-like acute cutaneous lupus erythematosus: report of a case and review of the literature Permalink","volume":"24","author":"Romero","year":"2018","journal-title":"Dermatol Online J"},{"issue":"8","key":"10.1016\/j.berh.2019.101440_bib38","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1177\/0961203313492242","article-title":"A case of toxic epidermal necrolysis-like skin lesions with systemic lupus erythematosus and review of the literature","volume":"22","author":"Yildirim Cetin","year":"2018","journal-title":"Lupus"},{"issue":"12","key":"10.1016\/j.berh.2019.101440_bib39","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1177\/0961203317699714","article-title":"A 12-year retrospective review of bullous systemic lupus erythematosus in cutaneous and systemic lupus erythematosus patients","volume":"26","author":"Chanprapaph","year":"2017","journal-title":"Lupus"},{"key":"10.1016\/j.berh.2019.101440_bib40","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1177\/0961203318776104","article-title":"A 12-year retrospective review of bullous systemic lupus erythematosus in cutaneous and systemic lupus erythematosus patients","volume":"27","author":"Pons-Estel","year":"2018","journal-title":"Lupus"},{"issue":"6","key":"10.1016\/j.berh.2019.101440_bib41","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1191\/096120300678828569","article-title":"The spectrum of cutaneous manifestations in lupus erythematosus--the Italian experience","volume":"9","author":"Cardinali","year":"2000","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.berh.2019.101440_bib42","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.autrev.2017.11.025","article-title":"Nailfold capillaroscopy in systemic lupus erythematosus: a systematic review and critical appraisal","volume":"17","author":"Cutolo","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.berh.2019.101440_bib43","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2018-000291","article-title":"Alopecias in lupus erythematosus","volume":"5","author":"Concha","year":"2018","journal-title":"Lupus Sci Med"},{"key":"10.1016\/j.berh.2019.101440_bib44","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.jaut.2013.11.005","article-title":"The clinical features, diagnosis and classification of dermatomyositis","volume":"48\u201349","author":"Iaccarino","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.berh.2019.101440_bib45","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/s13613-018-0433-3","article-title":"Clinical features and outcome of patients with acute respiratory failure revealing anti - synthetase or anti - MDA - 5 dermato - pulmonary syndrome: a French multicenter retrospective study","volume":"8","author":"Vuillard","year":"2018","journal-title":"Ann Intensive Care"},{"issue":"3","key":"10.1016\/j.berh.2019.101440_bib46","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s12016-017-8652-1","article-title":"Cutaneous manifestations of dermatomyositis: a comprehensive review","volume":"53","author":"Mainetti","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.berh.2019.101440_bib47","article-title":"Developping classification for skin predominant dermatomyositis: the Delphi process","volume":"0\u20133","author":"Concha","year":"2019","journal-title":"Br J Dermatol"},{"issue":"5","key":"10.1016\/j.berh.2019.101440_bib48","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/mus.24566","article-title":"An overview of polymyositis and dermatomyositis","volume":"51","author":"Findlay","year":"2015","journal-title":"Muscle Nerve"},{"issue":"24","key":"10.1016\/j.berh.2019.101440_bib49","first-page":"318","article-title":"Redefining dermatomyositis: a description of new diagnostic criteria that differentiate pure dermatomyositis from overlap myositis with dermatomyositis features","volume":"93","author":"Troyanov","year":"2014","journal-title":"Med (United States)"},{"issue":"6","key":"10.1016\/j.berh.2019.101440_bib50","doi-asserted-by":"crossref","first-page":"418","DOI":"10.3109\/09546634.2012.697540","article-title":"Review of dermatomyositis: establishing the diagnosis and treatment algorithm","volume":"24","author":"Strowd","year":"2013","journal-title":"J Dermatol Treat"},{"issue":"August 2018","key":"10.1016\/j.berh.2019.101440_bib51","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.jid.2018.08.017","article-title":"Advances in cutaneous lupus erythematosus and Dermatomyositis\u202f: a report from the 4th international conference on cutaneous lupus erythematosus \u2014 an ongoing need for international consensus and collaborations","volume":"139","author":"Concha","year":"2019","journal-title":"J Invest Dermatol"},{"issue":"e000850","key":"10.1016\/j.berh.2019.101440_bib52","first-page":"1","article-title":"MRI of skeletal muscles in patients with idiopathic inflammatory myopathies\u202f: characteristic findings and diagnostic performance in dermatomyositis","volume":"5","author":"Ukichi","year":"2019","journal-title":"Rheum Musculoskelet Dis RMD Open"},{"issue":"1","key":"10.1016\/j.berh.2019.101440_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12948-018-0084-9","article-title":"Bench to bedside review of myositis autoantibodies","volume":"16","author":"Palterer","year":"2018","journal-title":"Clin Mol Allergy"},{"issue":"3","key":"10.1016\/j.berh.2019.101440_bib54","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jaad.2014.12.009","article-title":"Distinctive cutaneous and systemic features associated with antitranscriptional intermediary factor-1\u03b3 antibodies in adults with dermatomyositis","volume":"72","author":"Fiorentino","year":"2015","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.berh.2019.101440_bib55","first-page":"15","article-title":"The importance of new specific autoantibodies in dermatomyositis","volume":"77","author":"Calv\u00e3o","year":"2019","journal-title":"Rev Soc Port Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.berh.2019.101440_bib56","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s12016-015-8496-5","article-title":"Cutaneous manifestations in Dermatomyositis\u202f: key clinical and serological features \u2014 a comprehensive review","volume":"51","author":"Muro","year":"2015","journal-title":"Clin Rev Allergy Immunol"},{"issue":"4","key":"10.1016\/j.berh.2019.101440_bib57","doi-asserted-by":"crossref","DOI":"10.1111\/micc.12447","article-title":"Automated assessment of absolute nailfold capillary number on videocapillaroscopic images: proof of principle and validation in systemic sclerosis","volume":"25","author":"Cutolo","year":"2018","journal-title":"Microcirculation"},{"issue":"1","key":"10.1016\/j.berh.2019.101440_bib58","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s12016-015-8517-4","article-title":"The clinical and histological spectrum of idiopathic inflammatory myopathies","volume":"52","author":"Cavazzana","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"issue":"84","key":"10.1016\/j.berh.2019.101440_bib59","first-page":"1","article-title":"Clinical phenotypes and biologic treatment use in juvenile dermatomyositis-associated calcinosis","volume":"16","author":"Orandi","year":"2018","journal-title":"Pediatr Rheum"},{"issue":"7","key":"10.1016\/j.berh.2019.101440_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.21037\/atm.2017.03.94","article-title":"MDA5 autoantibody \u2014 another indicator of clinical diversity in dermatomyositis","volume":"5","author":"Sontheimer","year":"2017","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.berh.2019.101440_bib62","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1136\/annrheumdis-2016-209247","article-title":"Consensus-based recommendations for the management of juvenile dermatomyositis","volume":"76","author":"Enders","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"10.1016\/j.berh.2019.101440_bib63","doi-asserted-by":"crossref","first-page":"256","DOI":"10.2340\/00015555-3091","article-title":"Use of anti-transcriptional intermediary factor-1 gamma autoantibody in identifying adult dermatomyositis patients with cancer: a systematic review and meta-analysis","volume":"99","author":"Best","year":"2019","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"10.1016\/j.berh.2019.101440_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12016-015-8510-y","article-title":"A comprehensive overview on myositis-specific antibodies: new and old biomarkers in idiopathic inflammatory myopathy","volume":"52","author":"Satoh","year":"2018","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.berh.2019.101440_bib65","article-title":"Anti-MDA5 antibodies in a large mediterranean population of adults with dermatomyositis","volume":"1\u20138","author":"Labrador-horrillo","year":"2014","journal-title":"J Immunol Res"},{"issue":"7","key":"10.1016\/j.berh.2019.101440_bib66","doi-asserted-by":"crossref","first-page":"909","DOI":"10.6061\/clinics\/2013(07)04","article-title":"Myositis-specific and myositis-associated autoantibody profiles and their clinical associations in a large series of patients with polymyositis and dermatomyositis","volume":"68","author":"Cruellas","year":"2013","journal-title":"Clin (S\u00e3o Paulo)"},{"issue":"1","key":"10.1016\/j.berh.2019.101440_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MAJ.0b013e3182a55d24","article-title":"The primary care physician in the early diagnosis of systemic sclerosis: the cornerstone of recognition and hope","volume":"347","author":"Saketkoo","year":"2014","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.berh.2019.101440_bib68","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1136\/annrheumdis-2018-213455","article-title":"Progressive skin fibrosis is associated with a decline in lung function and worse survival in patients with diffuse cutaneous systemic sclerosis in the European Scleroderma Trials and Research ( EUSTAR ) cohort","volume":"78","author":"Wu","year":"2019","journal-title":"Ann Rheum Dis"},{"issue":"13","key":"10.1016\/j.berh.2019.101440_bib69","first-page":"1","article-title":"Interstitial lung disease associated with systemic sclerosis ( SSc-ILD )","volume":"20","author":"Cottin","year":"2019","journal-title":"Respir Res"},{"issue":"6","key":"10.1016\/j.berh.2019.101440_bib70","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s13075-019-1919-6","article-title":"Skin thickness score as a surrogate marker of organ involvements in systemic sclerosis\u202f: a retrospective observational study","volume":"21","author":"Matsuda","year":"2019","journal-title":"Arthritis Res Ther"},{"issue":"86","key":"10.1016\/j.berh.2019.101440_bib71","first-page":"1","article-title":"Survival and prognosis factors in systemic sclerosis: data of a French multicenter cohort, systematic review and meta-analysis of the literature","volume":"21","author":"Pokeerbux","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/j.berh.2019.101440_bib72","first-page":"2","article-title":"Antinuclear antibodies in systemic Sclerosis\u202f: an update","author":"Stochmal","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"issue":"7","key":"10.1016\/j.berh.2019.101440_bib73","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1111\/jdv.14914","article-title":"The role of the dermatologist in Raynaud \u2019 s phenomenon\u202f: a clinical challenge","volume":"32","author":"Nagaraja","year":"2018","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"1","key":"10.1016\/j.berh.2019.101440_bib74","doi-asserted-by":"crossref","first-page":"87","DOI":"10.4103\/njms.NJMS_3_18","article-title":"Facial tumor as a presenting complaint in a patient with primary Sj\u00f6gren\u2019 s syndrome","volume":"10","author":"Gonz\u00e1lez-mourelle","year":"2019","journal-title":"Natl J Maxillofac Surg"},{"key":"10.1016\/j.berh.2019.101440_bib75","series-title":"Cutaneous manifestations of rheumatic diseases","first-page":"135","article-title":"Mucocutaneous manifestations of Sjogren syndrome","author":"Flint","year":"2004"},{"issue":"4","key":"10.1016\/j.berh.2019.101440_bib76","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jaad.2018.05.021","article-title":"Cutaneous features and diagnosis of primary Sjogren syndrome: an update and review","volume":"79","author":"Jhorar","year":"2018","journal-title":"J Am Acad Dermatol"},{"issue":"2","key":"10.1016\/j.berh.2019.101440_bib77","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000477375","article-title":"Erythema gyratum repens-like purpura in a patient with sj\u00f6gren syndrome","volume":"9","author":"Fukunaga","year":"2017","journal-title":"Case Rep Dermatol"},{"key":"10.1016\/j.berh.2019.101440_bib78","series-title":"Livedoid vasculopathy and hypercoagulability in a patient with primary Sj\u00f6gren \u2019s syndrome","first-page":"431","author":"Cardoso","year":"2007"},{"issue":"1","key":"10.1016\/j.berh.2019.101440_bib79","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.berh.2012.01.009","article-title":"Mixed connective tissue disease: an overview of clinical manifestations, diagnosis and treatment","volume":"26","author":"Ortega-Hernandez","year":"2012","journal-title":"Best Pr Res Clin Rheumatol"},{"issue":"284","key":"10.1016\/j.berh.2019.101440_bib80","first-page":"1","article-title":"Disease evolution in mixed connective tissue disease\u202f: results from a long-term nationwide prospective cohort study","volume":"19","author":"Reiseter","year":"2017","journal-title":"Arthritis Res Ther"},{"issue":"11","key":"10.1016\/j.berh.2019.101440_bib81","first-page":"1","article-title":"Adult-onset Still's disease with atypical cutaneous manifestations","volume":"96","author":"Juarez","year":"2017","journal-title":"Med Balt"},{"issue":"3","key":"10.1016\/j.berh.2019.101440_bib82","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.det.2015.03.004","article-title":"Rheumatoid nodules","volume":"33","author":"Tilstra","year":"2015","journal-title":"Dermatol Clin"},{"issue":"2","key":"10.1016\/j.berh.2019.101440_bib83","first-page":"243","article-title":"Skin manifestations of rheumatoid arthritis","volume":"153","author":"Viviana","year":"2018","journal-title":"G Ital di Dermatologia e Venereol"},{"issue":"3","key":"10.1016\/j.berh.2019.101440_bib84","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s12016-017-8632-5","article-title":"Skin manifestations of rheumatoid arthritis, juvenile idiopathic arthritis, and spondyloarthritides","volume":"53","author":"Chua-Aguilera","year":"2017","journal-title":"Clin Rev Allergy Immunol"},{"issue":"6","key":"10.1016\/j.berh.2019.101440_bib85","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.ad.2015.02.005","article-title":"Nail psoriasis as a predictor of the development of psoriatic arthritis","volume":"106","author":"Raposo","year":"2015","journal-title":"Actas Dermosifiligr"},{"issue":"1","key":"10.1016\/j.berh.2019.101440_bib86","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.clindermatol.2013.05.037","article-title":"The red face revisited: connective tissue disorders","volume":"32","author":"Kazandjeva","year":"2014","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.berh.2019.101440_bib87","series-title":"European handbook of dermatological treatments","first-page":"233","article-title":"Drug photosensitivity","author":"Gon\u00e7alo","year":"2015"},{"issue":"4","key":"10.1016\/j.berh.2019.101440_bib88","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1111\/cod.12432","article-title":"European Society of Contact Dermatitis guideline for diagnostic patch testing - recommendations on best practice","volume":"73","author":"Johansen","year":"2015","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.berh.2019.101440_bib89","series-title":"Cutaneous manifestations of rheumatic diseases","first-page":"205","article-title":"Miscellaneous rheumatic diseases that can involve the skin","author":"Moschella","year":"2004"},{"issue":"6","key":"10.1016\/j.berh.2019.101440_bib90","first-page":"556","article-title":"Raynaud's phenomenon","volume":"375","author":"Wigley","year":"2016","journal-title":"New Times"},{"key":"10.1016\/j.berh.2019.101440_bib91","series-title":"Montagna's Trichology Diseases of the pilosebaceous follicle","first-page":"955","article-title":"Alopecias in systemic diseases","author":"Estrada","year":"2017"},{"issue":"March","key":"10.1016\/j.berh.2019.101440_bib92","first-page":"127","article-title":"Extracutaneous manifestations of localized Scleroderma\u202f: a review","volume":"76","author":"Morgado","year":"2018","journal-title":"Rev Soc Port Dermatol Venereol"},{"key":"10.1016\/j.berh.2019.101440_bib93","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2147\/CCID.S61202","article-title":"Pyoderma gangrenosum: challenges and solutions","volume":"8","author":"Gameiro","year":"2015","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"April","key":"10.1016\/j.berh.2019.101440_bib94","first-page":"1","article-title":"Immunoglobulin E-mediated autoimmunity","volume":"9","author":"Maurer","year":"2018","journal-title":"Front Immunol"},{"key":"10.1016\/j.berh.2019.101440_bib95","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1111\/cea.12673","article-title":"Comorbidity and pathogenic links of chronic spontaneous urticaria and systemic lupus erythematosus \u2013 a systematic review","volume":"46","author":"Kolkhir","year":"2015","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.berh.2019.101440_bib96","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.msard.2019.02.020","article-title":"Hypocomplementemic urticarial vasculitis and multiple Sclerosis\u202f: a rare association or an atypical presentation\u202f?","volume":"30","author":"Dur\u00e3es","year":"2019","journal-title":"Mult Scler Rel Dis"},{"key":"10.1016\/j.berh.2019.101440_bib97","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.arcped.2017.12.001","article-title":"Dermatological features of auto-inflammatory recurrent fevers","volume":"25","author":"Escudier","year":"2018","journal-title":"Arch P\u00e9diatrie"},{"issue":"4","key":"10.1016\/j.berh.2019.101440_bib98","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.jaip.2018.05.006","article-title":"Mimickers of Urticaria\u202f: urticarial vasculitis and autoinflammatory diseases","volume":"6","author":"Davis","year":"2018","journal-title":"J Allergy Clin Immunol Pr"},{"issue":"5","key":"10.1016\/j.berh.2019.101440_bib99","doi-asserted-by":"crossref","DOI":"10.1111\/ced.12828","article-title":"Clinical characterization and long-term follow-up of Schnitzler syndrome","volume":"41","author":"Gameiro","year":"2016","journal-title":"Clin Exp Dermatol"},{"issue":"10","key":"10.1016\/j.berh.2019.101440_bib100","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1001\/jamadermatol.2018.2549","article-title":"Association between autoantibody phenotype and cutaneous adverse reactions to hydroxychloroquine in dermatomyositis","volume":"154","author":"Wolstencroft","year":"2018","journal-title":"JAMA Dermatol"}],"container-title":["Best Practice & Research Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694219301251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521694219301251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T17:20:35Z","timestamp":1761499235000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521694219301251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":97,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S1521694219301251"],"URL":"https:\/\/doi.org\/10.1016\/j.berh.2019.101440","relation":{},"ISSN":["1521-6942"],"issn-type":[{"value":"1521-6942","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suspected inflammatory rheumatic diseases in patients presenting with skin rashes","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Rheumatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.berh.2019.101440","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101440"}}